Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: Do patients with a complete pathological response differ from those with residual tumour in the breast?

Breast Cancer Research and Treatment

Volumn 93, Issue 2, 2005, Pages 151-158

  Chaturvedi, Shailesh ^a   McLaren, Catherine ^a   Schofield, Andrew C ^a   Ogston, Keith N ^a   Sarkar, Tarun K ^b   Hutcheon, Andrew W ^b   Miller, Iain D ^a   Heys, Steven D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Disease relapse; Primary chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PREDNISOLONE; TAMOXIFEN; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MINIMAL RESIDUAL DISEASE; OBSERVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; RELAPSE; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 25844524866     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-4615-y     Document Type: Article

References (26)

1. M De Lena R Zucali G Viganotti P Valagussa G Bonadonna 1978 Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer Cancer Chemother Pharmacol 1 53 59
2. C Jacquillat M Weil F Baillet C Borel G Auclerc MA de Maublanc M Housset G Forget L Thill C Soubrane 1990 Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer Cancer 66 119 129
3. SM Scholl B Asselain T Palangie T Dorval M Jouve E Garcia Giralt J Vilcoq JC Durand P Pouillart 1991 Neoadjuvant chemotherapy in operable breast cancer Eur J Cancer 27 1668 1671
4. A Eltahir SD Heys AW Hutcheon TK Sarkar I Smith LG Walker AK Ah-See O Eremin 1998 Am J Surg 175 127 132
5. L Mauriac G MacGrogan A Avril M Durand A Floquet M Debled JM Dilhuydy F Bonichon 1999 Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS) Ann Oncol 10 47 52
6. SM Scholl A Fourquet B Asselain JY Pierga JR Vilcoq JC Durand T Dorval T Palangie M Jouve P Beuzeboc 1994 Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6 Eur J Cancer 30A 645 652
7. VF Semiglazov EE Topuzov JL Bavli VM Moiseyenko OA Ivanova IK Seleznev AA Orlov NY Barash OM Golubeva OF Chepic 1994 Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer Ann Oncol 5 591 595
8. TJ Powles TF Hickish A Makris SE Ashley ME O'Brien VA Tidy S Casey AG Nash N Sacks D Cosgrove 1995 Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer J Clin Oncol 13 547 552
9. A Makris TJ Powles SE Ashley J Chang T Hickish VA Tidy AG Nash HT Ford 1998 A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 1179 1184
10. B Fisher J Bryant N Wolmark E Mamounas A Brown ER Fisher DL Wickerham M Begovic A DeCillis A Robidoux RG Margolese AB Cruz Jr JL Hoehn AW Lees NV Dimitrov Bear 1998 Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672 2685
11. IC Smith SD Heys AW Hutcheon ID Miller S Payne FJ Gilbert AK Ah-See O Eremin LG Walker TK Sarkar SP Eggleton KN Ogston 2002 Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel J Clin Oncol 20 1456 1466
12. SD Heys AW Hutcheon TK Sarkar KN Ogston ID Miller S Payne I Smith LG Walker O Eremin 2002 Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial Clin Breast Cancer 3 suppl 2 S69 S74
13. WG Cance LA Carey BF Calvo C Sartor L Sawyer DT Moore J Rosenman DW Ollila M Graham II 2002 Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival Ann Surg 236 295 303
14. A Ring A Webb S Ashley WH Allum S Ebbs G Gui NP Sacks G Walsh IE Smith 2003 Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 21 4540 4545
15. SA McIntosh KN Ogston S Payne ID Miler TK Sarkar AW Hutcheon SD Heys 2003 Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy Am J Surg 185 525 531
16. AB Miller B Hoogstraten M Staquet A Winkler 1981 Reporting results of cancer treatment Cancer 47 207 214
17. AW Hutcheon SD Heys TK Sarkar 2003 Neoadjuvant docetaxel in locally advanced breast cancer Breast Cancer Res Treat 79 suppl 1 S19 S24
18. B Fisher S Anderson J Bryant RG Margolese M Deutsch ER Fisher JH Jeong N Wolmark 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 1233 1241
19. U Veronesi N Cascinelli L Mariani M Greco R Saccozzi A Luini M Aguilar E Marubini 2002 Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 1227 1232
20. V Londero M Bazzocchi C Del Frate F Puglisi C Di Loreto G Francescutti C Zuiani 2004 Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy Eur Radiol 14 1371 1379
21. A Rieber HJ Brambs A Gabelmann V Heilmann R Kreienberg T Kuhn 2002 Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy Eur Radiol 12 1711 1719
22. A Khan A Dickler E Marcus J Coon A Ali A Babbo S Gupta-Burt 2003 Clinical outcome correlation of positron emission tomography (PET) in patients with locally advanced breast cancer (LABC) treated with neoadjuvant doxorubicin and docetaxel Int J Radiat Oncol Biol Phys 57 suppl S167
23. EF Vines C Le Pechoux R Arriagada 2003 Prophylactic cranial irradiation in small cell lung cancer Semin Oncol 30 38 46
24. N Wolmark J Wang E Mamounas J Bryant B Fisher 2001 Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 30 96 102
25. M Colleoni D Zahrieh RD Gelber G Viale A Luini P Veronesi M Intra V Galimberti G Renne A Goldhirsch 2003 Preoperative systemic treatment: prediction of responsiveness Breast 12 538 542
26. T Jarvinen K Holli T Kuukasjarvi JJ Isola 1998 Predictive value of topoisomerase II alpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer Br J Cancer 77 2267 2273